$120.00
In stock
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 | — | $120.00 |
| 2 | 63.33 % | $44.00 |
| 5 | 64.17 % | $43.00 |
| 8+ | 66.67 % | $40.00 |
Free bacteriostatic water with every order.
Chemical Formula: C₁₀₀H₁₆₂N₂₈O₂₉
Molecular Weight: ~2,046 g/mol
CAS Number: 188126-82-8
Structure: Synthetic peptide analog of growth hormone releasing hormone (GHRH) designed to stimulate growth hormone release
Form: Lyophilized peptide powder
Solubility: Soluble in sterile water or compatible buffer prior to use
Stability: Stable when refrigerated; limited stability once reconstituted
Half-Life: Short biologic activity; dependent on dose and experimental model
Storage: Store refrigerated at 36–46°F (2–8°C); protect from light and moisture
Binds to pituitary GHRH receptors to stimulate pulsatile growth hormone release
Increases downstream insulin-like growth factor 1 levels
Influences lipid metabolism and adipose tissue distribution in research models
Supports glucose and lipid pathway research through GH-mediated signaling
Promotes natural growth hormone secretion rather than direct GH administration
Studied for reductions in visceral adipose tissue
Explored for potential neuroprotective and cellular resilience effects
Studies show:
Increased growth hormone levels following tesamorelin administration
Secondary elevation of IGF-1 in research subjects
Dose-dependent endocrine response in controlled settings
Research indicates:
Reduced visceral adipose tissue in experimental models
Improved lean-to-fat ratio
Supports changes in metabolic markers related to fat metabolism
Evidence suggests:
Improvements in lipid metabolism and circulating cholesterol profiles
Enhanced fat oxidation signaling in metabolic studies
Studies show:
Minimal suppression of endogenous GH rhythm when used appropriately
Favorable hormonal activation in controlled research environments
Observed effects appear dose-dependent and transient.
Mild flushing, temporary lightheadedness, injection site irriatation
IGF-1 levels, blood glucose, pituitary hormone panels
Most safety data derive from clinical use in approved indications or controlled studies.
Independent laboratory testing confirms purity and composition
Purity
Batch
Date
